Autopsy report · NCT01397500

Hormone Treatment in Growth Hormone and Testosterone Deficient Patients

“Recruitment problems due to change of patient population at site.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 3 years 4 months before it stopped.
• 54 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Max-Planck-Institute of Psychiatry

Sponsor type

University, hospital or other

Conditions

Hormone Deficiency

Interventions

Genotropin; Testosterone undecannoate

Participants

54

Sites

1

Countries

Germany

Trials that died the same way

• Macular Edema Incidence/Severity Reduction With Nevanac
  “Patient recruitment difficulties” (85% match in meaning)
• Electrocochleography Along Cochlear Implant Auditory Rehabilitation
  “patient recruitment problem” (85% match in meaning)
• Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
  “Difficulties in patient recruitment” (85% match in meaning)
• Tibial Delayed Healing Pivotal Clinical Trial
  “Difficulty in patient recruitment” (83% match in meaning)
• Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients
  “Difficulty with patient recruitment” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.